References list

• Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
  Ahmad, Gul, et al. J. Infect. Dis. 2011 Nov;204: 1437-49
• Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
  De Swart, Rik L, et al. J. Virol. 2002 Nov;76: 11561-9
• Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoni.
  Fallon, Padraic G, et al. J. Infect. Dis. 2003 Mar 15;187: 939-45
• Pre-clinical safety evaluation of heat shock protein 65-MUC1 peptide fusion protein.
  Huo, Yan, et al. Regul. Toxicol. Pharmacol. 2007 Oct;49: 63-74
• Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection.
  Jacquelin, Béatrice, et al. PLoS Pathog. 2014 Jul;10: e1004241
• Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant.
  Jagessar, S Anwar, et al. J. Neuropathol. Exp. Neurol. 2010 Apr;69: 372-85
• Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosis.
  Jagessar, S Anwar, et al. J Neuroimmune Pharmacol 2012 Mar;7: 253-65
• Delayed neutralization of interferon-gamma prevents lethality in primate Gram-negative bacteremic shock.
  Lainée, Pierre, et al. Crit. Care Med. 2005 Apr;33: 797-805
• Plasma cytokine levels: Relationship to early maternal interactions in socially reared vervet monkeys (Cercopithecus aethiops sabaeus)
  Mark L. Laudenslager, et al. Brain, Behavior, and Immunity 2006;20: e34-e35
• Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.
  Mascarell, Laurent, et al. Vaccine 2006 Apr 24;24: 3490-9
• Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
  Polakos, N K, et al. J. Immunol. 2001 Mar 01;166: 3589-98
• Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.
  Rout, Namita, et al. PLoS Pathog. 2012 Sep;8: e1002928
• Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application.
  Sun, Shihui, et al. Crit. Care Med. 2018 May;46: e419-e425
• Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.
  Yee, JoAnn L, et al. Comp. Med. 2013;63: 508-14
• Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
  Zhang, Weidong, et al. J. Infect. Dis. 2010 Apr 01;201: 1105-12